Altimmune Inc., a clinical-stage biopharmaceutical company, has appointed Greg Weaver as Chief Financial Officer (CFO), effective immediately. Weaver will lead the Company’s finance and accounting functions, including SEC reporting and investor relations.   “We are pleased to welcome Greg to Altimmune’s executive team during such a pivotal time in our evolution. He has a wealth of experience that we believe will be invaluable as we enter a crucial period in the development of our lead program,...